Nuveen LLC Purchases Shares of 103,678 Definitive Healthcare Corp. $DH

Key Points

• Nuveen LLC has acquired a new stake in Definitive Healthcare Corp., purchasing 103,678 shares valued at approximately $300,000.
• Definitive Healthcare's stock has a current price of $4.00, with a market cap of $572.56 million and significant activity from institutional investors, owning 98.67% of the stock.
• Analysts have mixed ratings for Definitive Healthcare, with one upgrade to "buy" and an average price target of $4.73, indicating a consensus rating of "Hold".

Nuveen LLC acquired a new stake in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 103,678 shares of the company's stock, valued at approximately $300,000. Nuveen LLC owned approximately 0.10% of Definitive Healthcare at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the business. Invesco Ltd. lifted its stake in shares of Definitive Healthcare by 19.3% in the first quarter. Invesco Ltd. now owns 61,871 shares of the company's stock valued at $179,000 after buying an additional 10,012 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Definitive Healthcare by 70.6% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 250,152 shares of the company's stock valued at $723,000 after buying an additional 103,529 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of Definitive Healthcare by 9.1% in the first quarter. Charles Schwab Investment Management Inc. now owns 458,936 shares of the company's stock valued at $1,326,000 after buying an additional 38,443 shares in the last quarter. Meeder Asset Management Inc. bought a new position in shares of Definitive Healthcare in the first quarter valued at $76,000. Finally, Pinnacle Wealth Management Advisory Group LLC bought a new position in shares of Definitive Healthcare in the first quarter valued at $751,000. 98.67% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have weighed in on DH. Stifel Nicolaus raised their price objective on shares of Definitive Healthcare from $5.00 to $6.00 and gave the company a "buy" rating in a research note on Friday, August 8th. Robert W. Baird set a $4.00 target price on shares of Definitive Healthcare in a report on Friday, August 8th. Finally, Wall Street Zen upgraded shares of Definitive Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, June 21st. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $4.73.

Definitive Healthcare Stock Performance

NASDAQ:DH traded up $0.15 on Thursday, reaching $4.13. 286,978 shares of the company's stock were exchanged, compared to its average volume of 253,765. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.65 and a quick ratio of 1.65. The firm has a market cap of $591.17 million, a price-to-earnings ratio of -1.56 and a beta of 1.65. Definitive Healthcare Corp. has a 52 week low of $2.15 and a 52 week high of $5.68. The stock has a fifty day simple moving average of $3.97 and a 200-day simple moving average of $3.43.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.